← Back to Patent Explorer
US2864745A Expired / Lapsed US ⏱️ 0.0 years remaining

Glaucarubin amebicide

Assignee: Merck and Co Inc
•
Filing: 1956-11-14
•
Granted: 1958-12-16
•
Expires: 1976-11-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Henry M Shafer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 08:19
CPC Classifications
A; A61; A61K; A61K36/00; A61K36/18; A61K36/185; Y; Y02; Y02A; Y02A50/00; Y02A50/30

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 169 words
THE COMPOUND GLAUCARUBIN, AN ORGANIC SUBSTANCECE ADAPTED FOR THE THERAPEUTIC TREATMENT OF AMEBIASIS, HAVING THE EMPIRICAL FORMULA C25H36O10, FORMING A DI-HYDRO DERIVATIVE UPON HYDROGENATION, FORMING A HEXAACETYL DERIVATIVE HAVING A MELTING POINT OF 162*C. AND OPTICAL ROTATION IN PYRIDINE OF +49*, AND A PENTAACETYL MONOHYDROXY DERIVATIVE HAVING A MELTING POINT OF 227*C AND OPTICAL ROTATION IN PYRIDINE OF +26*, AND WHEN IN CRYSTALLINE FORM BEING FURTHER CHARACTERIZED AS EXHIBITING CHARACTERISTIC INFRA-RED ABSORPTION AT THE FOLLOWING WAVE LENGTHS EXPRESSED IN MICRONS: 2.93, 2.99, 5.69, 5.78, 5.99, 7.43, 7.53, 7.63, 7.80, 7.89, 8.18, 8.43, 8.72, 8.80, 8.90, 8.98, 9.14, 9.55, 9.69, 9.81, 10.02, 10.13, 10.38, 10.51, 10.83, 10.98, 11.18, 11.39, 11.91, 12.07, 12,27, 12.38, 12.58, 12.82, 13.22, AND 13.81 AS SHOWN IN THE ACCOMPANYING DRAWING, MELTING WITH DECOMPOSITION ATN AT 262-263*C., EXHIBITING OPTICAL ROTATION IN PYRIDINE (1%) OF +45* AND IN METHANOL (0.3%) OF +89*, AND HAVING SOLUBILITIES EXPRESSED IN MG./ML. AS FOLLOWS: >3.5 AND <4.8 IN ACTEIC ACID; >20.8 AND <26.2 IN 1% SODIUM CARBONATE SOLUTION; AND >200 IN PYRIDINE.
Claim 2
Dependent Claim 169 words
THE COMPOUND GLAUCARUBIN, AN ORGANIC SUBSTANCECE ADAPTED FOR THE THERAPEUTIC TREATMENT OF AMEBIASIS, HAVING THE EMPIRICAL FORMULA C25H36O10, FORMING A DI-HYDRO DERIVATIVE UPON HYDROGENATION, FORMING A HEXAACETYL DERIVATIVE HAVING A MELTING POINT OF 162*C. AND OPTICAL ROTATION IN PYRIDINE OF +49*, AND A PENTAACETYL MONOHYDROXY DERIVATIVE HAVING A MELTING POINT OF 227*C AND OPTICAL ROTATION IN PYRIDINE OF +26*, AND WHEN IN CRYSTALLINE FORM BEING FURTHER CHARACTERIZED AS EXHIBITING CHARACTERISTIC INFRA-RED ABSORPTION AT THE FOLLOWING WAVE LENGTHS EXPRESSED IN MICRONS: 2.93, 2.99, 5.69, 5.78, 5.99, 7.43, 7.53, 7.63, 7.80, 7.89, 8.18, 8.43, 8.72, 8.80, 8.90, 8.98, 9.14, 9.55, 9.69, 9.81, 10.02, 10.13, 10.38, 10.51, 10.83, 10.98, 11.18, 11.39, 11.91, 12.07, 12,27, 12.38, 12.58, 12.82, 13.22, AND 13.81 AS SHOWN IN THE ACCOMPANYING DRAWING, MELTING WITH DECOMPOSITION ATN AT 262-263*C., EXHIBITING OPTICAL ROTATION IN PYRIDINE (1%) OF +45* AND IN METHANOL (0.3%) OF +89*, AND HAVING SOLUBILITIES EXPRESSED IN MG./ML. AS FOLLOWS: >3.5 AND <4.8 IN ACTEIC ACID; >20.8 AND <26.2 IN 1% SODIUM CARBONATE SOLUTION; AND >200 IN PYRIDINE.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1961-12-15 1962-06-16 1962-12-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1965-12-15 1966-06-16 1966-12-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1969-12-15 1970-06-16 1970-12-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag